AR092939A1 - Vacuna contra cooperia - Google Patents
Vacuna contra cooperiaInfo
- Publication number
- AR092939A1 AR092939A1 ARP130103642A ARP130103642A AR092939A1 AR 092939 A1 AR092939 A1 AR 092939A1 AR P130103642 A ARP130103642 A AR P130103642A AR P130103642 A ARP130103642 A AR P130103642A AR 092939 A1 AR092939 A1 AR 092939A1
- Authority
- AR
- Argentina
- Prior art keywords
- nucleotide sequences
- cooperia
- proteins
- methods
- recombinant dna
- Prior art date
Links
- 241001126268 Cooperia Species 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 108020004511 Recombinant DNA Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241000244206 Nematoda Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Secuencias de nucleótidos que codifican antígenos de Cooperia, así como con moléculas de ADN recombinante que contienen a dichas secuencias de nucleótidos y con células huésped que expresan estas secuencias de nucleótidos. Se relaciona además con proteínas de Cooperia, con métodos para la producción de las proteínas, las secuencias de nucleótidos, moléculas de ADN recombinante y huéspedes. Aún más, se relaciona con vacunas que inducen una inmunidad protectora contra una infección por nematodos parásitos tales como especies del género Cooperia y con métodos para preparar dicha vacuna. Vector, uso, método de vacunación.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12187773 | 2012-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR092939A1 true AR092939A1 (es) | 2015-05-06 |
Family
ID=47018872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130103642A AR092939A1 (es) | 2012-10-09 | 2013-10-08 | Vacuna contra cooperia |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10105424B2 (es) |
| EP (1) | EP2906588B1 (es) |
| AR (1) | AR092939A1 (es) |
| BR (1) | BR112015007678B1 (es) |
| CA (1) | CA2886450C (es) |
| ES (1) | ES2717441T3 (es) |
| WO (1) | WO2014056885A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR092939A1 (es) * | 2012-10-09 | 2015-05-06 | Univ Gent | Vacuna contra cooperia |
| AU2018324195A1 (en) | 2017-09-01 | 2020-04-02 | Venn Biosciences Corporation | Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring |
| WO2024089248A1 (en) * | 2022-10-27 | 2024-05-02 | Universiteit Gent | Recombinant activation-associated secreted protein |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5084269A (en) | 1986-11-06 | 1992-01-28 | Kullenberg Fred W | Adjuvant for dose treatment with antigens |
| DE69101683T2 (de) | 1990-07-30 | 1994-07-21 | Akzo Nv | Rekombinantes Mareks-Krankheitsvirus. |
| US5525508A (en) | 1991-02-06 | 1996-06-11 | Biotech Australia Pty Limited | Haemonchus contortus vaccine |
| US6071518A (en) * | 1992-05-29 | 2000-06-06 | The Regents Of The University Of California | GP900 glycoprotein and fragments for treatment and detection/diagnosis of cryptosporidium |
| US5961970A (en) | 1993-10-29 | 1999-10-05 | Pharmos Corporation | Submicron emulsions as vaccine adjuvants |
| WO1998001550A2 (en) | 1996-07-04 | 1998-01-15 | Universiteit Utrecht | Vaccine against gastro-intestinal nematodes |
| KR20090051129A (ko) | 2004-04-05 | 2009-05-20 | 화이자 프로덕츠 인코포레이티드 | 미세유체화된 수중유 유화액 및 백신 조성물 |
| WO2009158729A2 (en) * | 2008-06-27 | 2009-12-30 | The Infectious Disease Research Institute Inc. | Compounds and methods for diagnosis and treatment of chagas disease |
| CA2739796C (en) | 2008-10-08 | 2018-11-06 | Idexx Laboratories, Inc. | Compositions and methods for detection of antibodies specific for anaplasma phagocytophilum (aph) and anaplasma platys (apl) |
| GB0922099D0 (en) | 2009-12-18 | 2010-02-03 | Moredun Res Inst | Parasite Vaccine |
| AR092939A1 (es) * | 2012-10-09 | 2015-05-06 | Univ Gent | Vacuna contra cooperia |
-
2013
- 2013-10-08 AR ARP130103642A patent/AR092939A1/es active IP Right Grant
- 2013-10-08 CA CA2886450A patent/CA2886450C/en active Active
- 2013-10-08 WO PCT/EP2013/070903 patent/WO2014056885A1/en active Application Filing
- 2013-10-08 EP EP13782991.7A patent/EP2906588B1/en active Active
- 2013-10-08 BR BR112015007678-5A patent/BR112015007678B1/pt active IP Right Grant
- 2013-10-08 US US14/434,111 patent/US10105424B2/en active Active
- 2013-10-08 ES ES13782991T patent/ES2717441T3/es active Active
-
2018
- 2018-09-10 US US16/126,536 patent/US10946077B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20180369349A1 (en) | 2018-12-27 |
| WO2014056885A1 (en) | 2014-04-17 |
| US10946077B2 (en) | 2021-03-16 |
| US10105424B2 (en) | 2018-10-23 |
| EP2906588B1 (en) | 2018-12-05 |
| CA2886450A1 (en) | 2014-04-17 |
| ES2717441T3 (es) | 2019-06-21 |
| CA2886450C (en) | 2021-10-26 |
| US20150265687A1 (en) | 2015-09-24 |
| BR112015007678A2 (pt) | 2017-08-08 |
| EP2906588A1 (en) | 2015-08-19 |
| BR112015007678B1 (pt) | 2022-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2018005265A2 (es) | Vacunas de ácido nucleico para el virus varicela-zóster | |
| BR112018008090A2 (pt) | vacina de vírus do herpes simplex. | |
| BR112013020070A2 (pt) | moléculas de ácido nucleico que codificam novos antígenos de herpes, vacina compreendendo as mesmas e métodos de uso das mesmas | |
| MX2022006603A (es) | Vacuna contra el virus de la influenza de amplio espectro. | |
| EA201891415A8 (ru) | Антигены вируса иммунодефицита человека, векторы, композиции и способы их применения | |
| PE20142406A1 (es) | Antigenos asociados a prostata y regimenes de inmunoterapia basados en vacuna | |
| MX346245B (es) | Proteina de fusion que comprende el mutante crm197 no toxico de toxina de difteria. | |
| MX2018010483A (es) | Inmunogenos para vacunacion contra vih. | |
| BR112012030746A2 (pt) | cepas hospedeiras fúngigas filamentosas e constructos de dna , e métodos de uso dos mesmos. | |
| PH12015500308A1 (en) | Hepatitis b virus core protein and surface antigen protein and vaccine comprising the same | |
| CO2018012513A2 (es) | Anticuerpos | |
| EA202092990A2 (ru) | Молекула нуклеиновой кислоты, кодирующая коровый белок вируса гепатита в, и вакцина, содержащая указанную молекулу | |
| BR112015000585A2 (pt) | cepas mutantes de mycoplasma hyopneumoniae | |
| MX2016013631A (es) | Celulas huespedes modificadas y usos de las mismas. | |
| PE20160662A1 (es) | Anticuerpos especificos para fcrn | |
| MX2016006758A (es) | Composiciones y metodos de vectores para inducir una respuesta inmunitaria mediante el uso de vectores de poxvirus. | |
| UY36617A (es) | Proteínas de fusión inmunogénicas para el tratamiento del cáncer | |
| BR112017004495A2 (pt) | variantes de celobiohidrolase e polinucleotídeos codificando as mesmas | |
| MX2015013304A (es) | Vacunas de nucleoproteina de la influenza. | |
| AR092939A1 (es) | Vacuna contra cooperia | |
| PH12017501100B1 (en) | Recombinant swinepox virus and vaccines | |
| BR112014014390A2 (pt) | levedura recombinante, seus usos, processo para vacinação, oligonucleotídeo, vetor de expressão, e método de produção de uma composição de vacina | |
| CU20150019A7 (es) | Rotavirus humanos modificados | |
| PL406631A1 (pl) | Antygen, szczepionka przeciwko grypie, układ do wytwarzania szczepionki, sposób wytwarzania antygenu oraz zastosowanie antygenu określonego powyżej do wytwarzania szczepionki przeciwko grypie | |
| WO2012178078A3 (en) | Use of yscf, truncated yscf and yscf homologs as adjuvants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |